Long Term Effectiveness of Mepolizumab in the Treatment of Chronic Eosinophilic Pneumonia
Saved in:
| Main Authors: | María Longás, Cindy S. Aponte, Daniel Laorden, David Romero, Santiago Quirce, Rodolfo Álvarez-Sala |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Open Respiratory Archives |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2659663625000669 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
by: Manuel David Gil-Sierra, et al.
Published: (2019-11-01) -
Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
by: Ravi Ranjan Pradhan, et al.
Published: (2019-01-01) -
The Effect of Mepolizumab on Blood Eosinophil Subtype Distribution and Granule Protein Gene Expression in Severe Eosinophilic Asthma
by: Rimkunas A, et al.
Published: (2025-03-01) -
Relapse of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Despite Maintenance Treatment With Low‐Dose Mepolizumab
by: Aurelie Vanthuyne, et al.
Published: (2025-05-01) -
Eosinophil and Cationic Protein Levels in Patients Treated With Dupilumab: A Real-Life Study
by: María Alejandra Castillo, et al.
Published: (2025-07-01)